Franz Humer, Ph.D.
Lead Independent DirectoratAllogene Therapeutics· In proxies 2016–2025
Franz Humer, Ph.D. sits on 11 public boards.
Boards2
- Allogene TherapeuticsLead independent director · 7 yr on the boardIndependentCompensation (Chair), International and Business Development Oversight (Chair)—Paid as an executive
- CitigroupDirector · 4 yr on the boardIndependentNomination, Governance and Public Affairs, Risk Management, Operations and Technology, Executive—Paid as an executive
-svg%3c/title%3e%3cstyle%3e%20.s0%20{%20fill:%20%23255be3%20}%20.s1%20{%20fill:%20%23ff3c28%20}%20%3c/style%3e%3cpath%20id='Layer'%20class='s0'%20d='m0.2%20604.2c0-159.9%20130.8-284.4%20301.1-284.4%2098.6%200%20188.6%2044%20240.1%20110.5l-74%2074.1c-19.6-25.1-44.6-45.5-73.2-59.7-28.6-14.1-59.9-21.6-91.8-21.9-101.8%200-183.2%2076.2-183.2%20181.4%200%20106.3%2081.4%20182.5%20183.2%20182.5%2033%200%2065.6-7.7%2095.1-22.4%2029.6-14.7%2055.3-36.1%2075.3-62.4l72.9%2071.9c-49.3%2069.8-143.6%20116-244.4%20116-170.3%200-301.1-124.5-301.1-285.6zm641.9-265.1h116.8v531.4h-116.8zm334.3%20388.5v-289.8h-127.5v-98.7h132.9v-113.8l109.3-53.7v167.5h173.6v98.7h-173.6v270.5c0%2053.7%2030%2077.3%2086.8%2077.3%2029.5%200.2%2058.8-6.1%2085.7-18.2v100.9c-33.7%2014.8-70.3%2022.1-107.1%2021.4-104%200-180.1-56.9-180.1-162.1zm380.4-388.5h116.8v531.3h-116.8z'/%3e%3cpath%20id='Layer'%20class='s1'%20d='m1056.8%201c95.9-0.3%20190.5%2022.6%20275.7%2066.7%2085.3%2044.1%20158.7%20108.1%20214%20186.6h-136.1c-44.6-49.7-99.1-89.4-160-116.6-61-27.2-126.9-41.2-193.6-41.2-66.7%200-132.6%2014-193.6%2041.2-60.9%2027.2-115.4%2066.9-160%20116.6h-136.1c55.3-78.5%20128.7-142.5%20214-186.6%2085.2-44.1%20179.8-67%20275.7-66.7z'/%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Allogene TherapeuticsPublic company · 3 yr
- Lead Independent Director2023 – Present · 3 yrStock in role -77%
- CitigroupPublic company · 10 yr
- Director2016 – Present · 10 yrNo stock prices for these years
- Kallyope, IncPublic company
- Director? – PresentNo stock prices for these years
- LetterOne Holdings S.A.Public company
- Director? – PresentNo stock prices for these years
- Glaxo HoldingsPublic company
- Director? – PresentNo stock prices for these years
- Neogene Therapeutics, Inc.Public company · 3 yr
- Director2020 – 2023 · 3 yrNo stock prices for these years
- WISeKey SAPublic company · 1 yr
- Director2016 – 2017 · 1 yrNo stock prices for these years
- KitePublic company · 2 yr
- Director2015 – 2017 · 2 yrNo stock prices for these years
- Kite Pharma, Inc.Public company · 2 yr
- Director2015 – 2017 · 2 yrNo stock prices for these years
- Chugai Pharmaceuticals Ltd.Public company · 12 yr
- Director2002 – 2014 · 12 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?